Home › Therapeutic areas › Neurology › Frontotemporal Dementia
Frontotemporal Dementia (5 companies)
Companies with an active program in Frontotemporal Dementia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ACIU | AC Immune | Neurology Rare | 1 | Phase 3 | $222M | 11 |
| CRVO | CervoMed | Neurology Rare | 1 | Phase 2 | $21.5M | 4 |
| COYA | Coya Therapeutics | Neurology Rare | 1 | Phase 2 | $70.1M | 6 |
| PMN | ProMIS Neurosciences | Neurology Rare | 1 | Phase 1 | $37.3M | 6 |
| VYGR | Voyager Therapeutics | MetabolicNeurology Rare | 2 | Phase 1 | $116M | 9 |
No companies match.